Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
2021-05-12–present
General Counsel
Kiniksa Pharmaceuticals International, plc (KNSA)Equibles does not estimate personal net worth.
Get an email with a short summary when Kiniksa Pharmaceuticals International, plc publishes a filing, an earnings call transcript or a press release.
Get KNSA alertsMadelyn Zeylikman is recorded as General Counsel at Kiniksa Pharmaceuticals International, plc (KNSA) since May 12, 2021. Kiniksa Pharmaceuticals International, plc reported in an 8-K filed May 12, 2021 that Madelyn Zeylikman was appointed General Counsel. Kiniksa Pharmaceuticals International, plc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Kiniksa Pharmaceuticals International, plc includes Sanj K. Patel (CEO and Board Member), Mark Ragosa (CFO), Ross Moat (COO) and 7 others.
“In conjunction therewith, the company appointed Madelyn Zeylikman, the company's Vice President, Legal, to General Counsel.”
2021-05-12–present
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
2021-05-12–present